Chen J, Wu C, Wang X, Yu J, Sun Z
Understanding available evidence and safer alternatives helps inform these critical decisions during the postpartum period
That means the worsening on re-escalation is tangled up with drug accumulation and cannot be put down to the dose increase alone, which softens the rechallenge-dependent Naranjo items and the dose-dependence story along with them
The recent SURMOUNT-OSA trial clearly showed that substantial weight loss significantly reduces OSA severity, especially through medications like Tirzepatide, commercially known as Zepbound (Malhotra et al., 2024)
In recent years, tirzepatide has gained significant attention in the medical community and among patients for its potential benefits in managing type 2 diabetes and aiding weight loss